The concept of antigen-driven autoimmune responses is the basis of this study to use antinuclear antibodies (ANAs) in hepatocellular carcinoma (HCC) as a model to identify other nuclear proteins which could be participating in carcinogenesis. Unique features about HCC are the high frequency (31%) of ANAs and dynamic changes in antibody responses during transformation from precursor chronic liver disease states to malignancy. A cDNA encoding alternative splicing factor HCC1 of the serine-arginine (SR) family has been isolated with this approach, and its relationship with carcinogenesis will be examined in HCC1 transgenic mice. Another cDNA encoding a cell cycle-related nuclear protein maximally expressed in S and G2, called SG2NA (SG2 nuclear antigen) will be analyzed for its role in cell cycle progression with complementation studies involving a yeast mutant. This ts mutant is deficient in CDC4, a yeast cell cycle protein which has similar structural motifs as SG2NA and is required for DNA replication and separation of the centrosome to form the poles of the mitotic spindle. Studies will be continued to identify other proteins involved in tumorigenesis with special emphasis devoted to using antibodies which are present during the precursor disease states (chronic hepatitis and liver cirrhosis CH/LC) and those which appear de novo with malignancy. HCC offers a unique opportunity for separating nuclear proteins involved in inflammatory conditions such as CH/LC from those involved in subsequent malignancy. Collaboration has been initiated and will be continued with hepatologists in Japan who have a cohort of about 600 patients with CH/LC under long-term clinical surveillance. Patients converting to HCC can be immediately identified and serum and liver biopsies obtained for these studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA056956-07
Application #
2894940
Study Section
Metabolic Pathology Study Section (MEP)
Program Officer
Mccarthy, Susan A
Project Start
1992-04-01
Project End
2001-01-16
Budget Start
1999-05-01
Budget End
2001-01-16
Support Year
7
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Tybl, Elisabeth; Shi, Fu-Dong; Kessler, Sonja M et al. (2011) Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol 54:994-1001
Liu, Weihong; Peng, Bo; Lu, Yumin et al. (2011) Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev 10:331-5
Zhang, Jian-Ying; Tan, Eng M (2010) Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn 10:321-8
Chen, Yao; Zhou, Yusen; Qiu, Suimin et al. (2010) Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett 289:32-9
Rom, William N; Goldberg, Judith D; Addrizzo-Harris, Doreen et al. (2010) Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer 10:234
Zhang, Jian-Ying; Looi, Kok Sun; Tan, Eng M (2009) Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Methods Mol Biol 520:1-10
Tan, Eng M; Zhang, Jianying (2008) Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 222:328-40
Zhang, Jian-Ying (2007) Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev 6:143-8
Zhang, Jian-Ying; Megliorino, Roxanne; Peng, Xuan-Xian et al. (2007) Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol 46:107-14
Ersvaer, Elisabeth; Zhang, Jian-Ying; McCormack, Emmet et al. (2007) Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. Eur J Haematol 79:210-25

Showing the most recent 10 out of 48 publications